Почетна › Немалоклетни карцином плућа › Вирџинија › Arlington
Kliničke studije za Немалоклетни карцином плућа u gradu Arlington, VA
111 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Arlington i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Тражи се учесникФаза 1/2
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 ми удаљено
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Тражи се учесникФаза 2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Тражи се учесникФаза 3
- Virginia Cancer Specialists ( Site 0114), Fairfax · 11 ми удаљено
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Тражи се учесникФаза 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 ми удаљено
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
- NEXT Virginia, Fairfax · 11 ми удаљено
A KRAS Inhibitor in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- NEXT, Fairfax · 11 ми удаљено
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
Тражи се учесникФаза 1
- Virginia Cancer Specialists, PC, Fairfax · 11 ми удаљено
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of DS-3939a in Participants With Solid Tumors
Тражи се учесникФаза 1/2
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
Тражи се учесникФаза 2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Тражи се учесникФаза 1
- NEXT Texas LLC - Virginia, Fairfax · 11 ми удаљено
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
Тражи се учесникФаза 3
- Local Institution - 0165, Fairfax · 11 ми удаљено
- Local Institution - 0530, Fairfax · 11 ми удаљено
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Тражи се учесникФаза 3
- Research Site, Fairfax · 11 ми удаљено
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Тражи се учесникФаза 3
- Virginia Cancer Specialists ( Site 0167), Fairfax · 11 ми удаљено
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Тражи се учесникФаза 3
- Virginia Cancer Specialists, Arlington
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
A 2-part Phase 1/2 Open-label Trial on ODM-212
Тражи се учесникФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Тражи се учесникФаза 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Тражи се учесникФаза 1
- Inova Schar Cancer Institute, Falls Church · 4 ми удаљено
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- USO - Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
XTX501 in Patients With Metastatic Non-Small Cell Lung Cancer and Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Investigator Site, Fairfax · 11 ми удаљено
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
Тражи се учесникФаза 2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Тражи се учесникФаза 1
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Тражи се учесникФаза 2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Тражи се учесникФаза 2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Тражи се учесникФаза 2/3
- Virginia Cancer Specialists, PC, Fairfax · 11 ми удаљено
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1
- NEXT Virginia, LLC, Fairfax · 11 ми удаљено
CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Clinical Study Site, Fairfax · 11 ми удаљено
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
Тражи се учесникФаза 2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Тражи се учесникФаза 2/3
- Inova Schar Cancer, Fairfax · 11 ми удаљено
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
Тражи се учесникФаза 3
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Тражи се учесникФаза 3
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Тражи се учесникФаза 3
- Virginia Cancer Specialists, PC, Fairfax · 11 ми удаљено
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Тражи се учесникФаза 2/3
- Local Institution - 007-814-D, Arlington
- USOR - Virginia Cancer Specialists - Fairfax Office, Fairfax · 11 ми удаљено
Study of XB010 in Subjects With Solid Tumors
Тражи се учесникФаза 1
- Inova Schar Cancer, Fairfax · 11 ми удаљено
- NEXT Virginia, Fairfax · 11 ми удаљено
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 3
- Research Site, Fairfax · 11 ми удаљено
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Тражи се учесникФаза 1
- Inova Schar Cancer Institute, Falls Church · 4 ми удаљено
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
Тражи се учесникФаза 2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Тражи се учесникФаза 1
- Research Site, Fairfax · 11 ми удаљено
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 1
- Virginia Cancer Specialists PC, Fairfax · 11 ми удаљено
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 2
- Virginia Cancer Specialists - Fairfax /ID# 272004, Fairfax · 11 ми удаљено
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Тражи се учесникФаза 2
- Research Site, Fairfax · 11 ми удаљено
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Research Site 102, Fairfax · 11 ми удаљено
- Research Site 112, Fairfax · 11 ми удаљено
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Тражи се учесникФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 2
- Research Site, Fairfax · 11 ми удаљено
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Clinical Trial Site, Fairfax · 11 ми удаљено
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Тражи се учесникФаза 3
- Virginia Cancer Specialists - Arlington Office, Arlington
- Virginia Cancer Specialists - Fairfax Office, Fairfax · 11 ми удаљено
- Virginia Cancer Specialists - Reston, Reston · 14 ми удаљено
- и још 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 ми удаљено
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 ми удаљено
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Research Site, Fairfax · 11 ми удаљено
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Тражи се учесникФаза 1
- Site 04, Fairfax · 11 ми удаљено
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Тражи се учесникФаза 1
- ALX Center 2, Fairfax · 11 ми удаљено
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Тражи се учесникФаза 3
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of PHN-012 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- PHN-012-001 Site, Fairfax · 11 ми удаљено
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Тражи се учесникФаза 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 ми удаљено
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Тражи се учесникФаза 1
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Тражи се учесникФаза 3
- Clinical Study Site, Fairfax · 11 ми удаљено
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Тражи се учесникФаза 1
- NEXT - Virginia, Fairfax · 11 ми удаљено
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Тражи се учесникФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Тражи се учесникФаза 1
- NEXT Oncology, Fairfax · 11 ми удаљено
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Тражи се учесникФаза 1
- Virginia Cancer Specialists, PC, Fairfax · 11 ми удаљено
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Тражи се учесникФаза 1
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- Research Site, Fairfax · 11 ми удаљено
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Тражи се учесникФаза 3
- Inova Schar Cancer Institute, Fairfax · 11 ми удаљено
- Inova Fair Oaks Hospital, Fairfax · 11 ми удаљено
A Study of DM005 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 ми удаљено
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Next Virginia, Fairfax · 11 ми удаљено
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
Тражи се учесникФаза 1/2
- Research Site, Fairfax · 11 ми удаљено
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Тражи се учесникФаза 1
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Тражи се учесникФаза 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 ми удаљено
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Research Site, Fairfax · 11 ми удаљено
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Тражи се учесникФаза 1
- NEXT Oncology Virginia, Fairfax · 11 ми удаљено
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 ми удаљено
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Тражи се учесникФаза 3
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
Тражи се учесникФаза 1/2
- NEXT Oncology, Fairfax · 11 ми удаљено
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Тражи се учесникФаза 1/2
- Next Oncology Virginia, Fairfax · 11 ми удаљено
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Тражи се учесникФаза 2
- Inova Fairfax Hospital, Fairfax · 11 ми удаљено
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Тражи се учесникФаза 1
- Research Site, Fairfax · 11 ми удаљено
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- NEXT Virginia, Fairfax · 11 ми удаљено
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Тражи се учесникФаза 1/2
- NEXT, Virginia, Fairfax · 11 ми удаљено
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Тражи се учесникФаза 1
- Dren Investigational Site, Fairfax · 11 ми удаљено
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Тражи се учесникФаза 1
- NEXT Oncology, Fairfax · 11 ми удаљено
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Тражи се учесникФаза 1/2
- Virginia Cancer Specialists, Fairfax · 11 ми удаљено
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Тражи се учесникФаза 1/2
- NEXT Virginia, Fairfax · 11 ми удаљено
Studije za Немалоклетни карцином плућа u drugim gradovima
- Houston, TX143 студија
- New York City, NY123 студија
- Nashville, TN97 студија
- Los Angeles, CA92 студија
- Boston, MA87 студија
- St. Louis, MO68 студија
- Baltimore, MD60 студија
- San Antonio, TX60 студија
- Chicago, IL59 студија
- Columbus, OH57 студија
- Seattle, WA55 студија
- Washington, DC55 студија
Ostale studije u gradu Arlington
- Колоректални карцином54 студија
- Метастатски карцином52 студија
- Рак (све врсте)52 студија
- Рак дојке50 студија
- Рак јајника47 студија
- Рак плућа42 студија
- Карцином ендометријума41 студија
- Рак панкреаса33 студија
- Плоскоклеточни карцином главе и врата29 студија
- Sitnoćelijski rak pluća22 студија
- Trostruko negativni rak dojke21 студија
- Рак желуца21 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.